These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29762860)

  • 1. New pathogens, new tricks: emerging, drug-resistant fungal pathogens and future prospects for antifungal therapeutics.
    Geddes-McAlister J; Shapiro RS
    Ann N Y Acad Sci; 2019 Jan; 1435(1):57-78. PubMed ID: 29762860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coping with stress and the emergence of multidrug resistance in fungi.
    Shor E; Perlin DS
    PLoS Pathog; 2015 Mar; 11(3):e1004668. PubMed ID: 25790300
    [No Abstract]   [Full Text] [Related]  

  • 3. Antifungal resistance: an emerging battlefield.
    Woo PC; Tsang CC; Lau SK
    Future Microbiol; 2020 May; 15():571-574. PubMed ID: 32484001
    [No Abstract]   [Full Text] [Related]  

  • 4. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.
    Savini V; Catavitello C; Onofrillo D; Masciarelli G; Astolfi D; Balbinot A; Febbo F; D'Amario C; D'Antonio D
    Mycoses; 2011 Sep; 54(5):434-41. PubMed ID: 21039941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.
    Gamaletsou MN; Walsh TJ; Sipsas NV
    Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents.
    Spampinato C; Leonardi D
    Biomed Res Int; 2013; 2013():204237. PubMed ID: 23878798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
    Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug development challenges and strategies to address emerging and resistant fungal pathogens.
    McCarthy MW; Walsh TJ
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):577-584. PubMed ID: 28480775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.
    Pfaller MA
    Am J Med; 2012 Jan; 125(1 Suppl):S3-13. PubMed ID: 22196207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging fungal resistance.
    Baddley JW; Moser SA
    Clin Lab Med; 2004 Sep; 24(3):721-35, vii. PubMed ID: 15325062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Repurposing of Haloperidol: Discovery of New Benzocyclane Derivatives as Potent Antifungal Agents against Cryptococcosis and Candidiasis.
    Ji C; Liu N; Tu J; Li Z; Han G; Li J; Sheng C
    ACS Infect Dis; 2020 May; 6(5):768-786. PubMed ID: 31550886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
    Schmiedel Y; Zimmerli S
    Swiss Med Wkly; 2016; 146():w14281. PubMed ID: 26901377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Detection of Resistance to Echinocandins.
    Posteraro B; Vella A; De Carolis E; Sanguinetti M
    Methods Mol Biol; 2017; 1508():413-421. PubMed ID: 27837518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: A 10-year study.
    Sasso M; Roger C; Sasso M; Poujol H; Barbar S; Lefrant JY; Lachaud L
    Mycoses; 2017 Dec; 60(12):770-780. PubMed ID: 28758337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.
    Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
    FEMS Microbiol Rev; 2012 Mar; 36(2):288-305. PubMed ID: 21569057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
    da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antifungal therapy against Candida species: the new frontier--are we there yet?
    Vazquez JA
    Med Mycol; 2003 Oct; 41(5):355-68. PubMed ID: 14653512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal drug resistance: limited data, dramatic impact?
    Rogers TR
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():7-11. PubMed ID: 16701982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcosis: update and emergence of Cryptococcus gattii.
    Lester SJ; Malik R; Bartlett KH; Duncan CG
    Vet Clin Pathol; 2011 Mar; 40(1):4-17. PubMed ID: 21244455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.